| 摘要 |
There is described a compound selected from the group consisting of trama dol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizo lirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or co mbinations thereof, for the treatment or alleviation of depression.
|
